Icon Group is proud to work with over 200 collaborators including Contract Research Organisations (CROs), commercial and non-commercial organisations (including the pharmaceutical industry, hospitals, and universities), industry vendors and service providers.
Clinical Oncology Society of Australia (COSA)
Icon collaborated with COSA for their Annual Scientific Meeting through facilitation of the Pre- Conference Workshop ‘Tele-trials, the new norm?’. In line with the virtual theme the workshop was also made available via Icon’s digital platforms to participants around the world. This split presentation model provided opportunities to a wide variety of industry partners and participants to gain the most out of these resources in a platform that works for them.
Queensland Institute of Medical Research (QIMR) Berghofer
In 2019, Icon Group signed a Memorandum of Understanding (MOU) with QIMR Berghofer. The MOU better enables Icon and QIMR Berghofer to translate cutting-edge research into clinical practice, with key areas of interest including new ways of diagnosing cancer and sharing information that could be used to genetically sequence cancers.
The University of Queensland (UQ) and Queensland University of Technology (QUT)
Icon continues to collaborate with leading Queensland universities, UQ and QUT to provide work-integrated learning placements to undergraduate students interested in pursuing a career in research.
Varian Medical Systems
Icon Group are proud to have a global partnership with radiation oncology industry leaders, Varian Medical Systems (Varian). This partnership has extended to research with the intention to establish an improved process for identification, prioritisation and support of Icon Investigator-Initiated projects that align with Varian’s values and vision to further advance radiation therapy techniques.
Wesley Medical Research
Icon and Wesley Medical Research (in Queensland) have a longstanding relationship and are currently collaborating on a retrospective analysis of survival outcomes following autologous haematopoietic stem cell transplantation (ASCT) in the private sector. Icon Cancer Centre performs the highest number of ASCT in Australasia with most transplants performed at The Wesley Hospital. This analysis will audit survival outcomes post-ASCT performed at Icon Cancer Centre, including the development of a comprehensive database to ensure the high quality of clinical outcomes.